Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
Date:2/19/2009

istent with 2007 levels.

Brand research and development increased 20 percent or $8.5 million to $50.9 million, due primarily to milestone payments made following the Rapaflo(TM) and Trelstar(R) New Drug Application (NDA) filings. The Company recently received FDA approval for Rapaflo(TM) (silodosin), its alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia. The Company plans to launch Rapaflo(TM) in late March. Additionally, the Company recently received FDA approval for Gelnique(TM) (oxybutynin chloride) Gel 10%, its topical gel for the treatment of overactive bladder. Watson plans to launch Gelnique(TM) in late April. Also, during the fourth quarter 2008, Watson filed an NDA with FDA for its six month formulation of Trelstar(R) (triptorelin pamoate for injection suspension). The Company anticipates that FDA will take action on the Trelstar(R) application in the third quarter of 2009.


    Distribution Segment Information

                                       Three Months Ended  Twelve Months Ended
                                           December 31,       December 31,
    (Unaudited; $ in thousands)          2008      2007      2008      2007
    Distribution Segment Contribution
      Net revenue                      $162,368  $144,107  $606,190  $566,053
      Cost of sales                     137,099   123,397   511,911   486,980
        Gross profit                     25,269    20,710    94,279    79,073
        Gross margin                      15.6%     14.4%     15.6%     14.0%
      Selling and marketing              15,819    12,777    59,514    52,023
        Segment contribution             $9,450    $7,933   $34,765   $27,050
        Segment margin                     5.8%      5.5%      5.7%      4.8%

Distribution segment net revenue for the fourth quarter of 2008 increased 13 percent or $18.3 million to $162.4 million. The increase w
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
2. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
3. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
4. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
5. U.S. Workers Taking Steps to Lower Medical Costs, Watson Wyatt Survey Finds
6. China Shenghuo Announces Additional Roll-Out of 12 Ways Cosmetics Products to Watsons Stores
7. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
8. Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
9. Watson Enters Into Agreement to Acquire Products Related to Tevas Proposed Acquisition of Barr
10. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
11. Watson Pharmaceuticals Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... -- Recent two-generation approaches to reducing poverty that ... attention from researchers, advocates, and foundations. By combining ... to move to jobs that offer a path ... education for children, these programs aim to improve ... to a new report from the National Center ...
(Date:9/22/2014)... UK (PRWEB) September 22, 2014 The ... in the recent years. The statistically important data received ... safety of cancer vaccines. The primary challenge to the ... information about the exact mechanism of how a human’s ... to various results in different individuals owing to known ...
(Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Scans ... they learn to read. This finding could potentially ... other reading difficulties early on, preliminary research suggests. ... in children with dyslexia as well as most ... Hoeft, an associate professor of child and adolescent ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 CareFlight ... has taken delivery of a new AS365 N3+ Dauphin, ... helicopter. The new aircraft, which is based at ... all-Dauphin fleet of four air medical transport helicopters. , ... said Candy Skidmore, Premier Health Vice President, Emergency, Trauma, ...
Breaking Medicine News(10 mins):Health News:Higher risk of heart disease for South Asians in Canada 2Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3
... 24 Catholic Charities,USA today urged Congress and ... come together to pass a comprehensive children,s health,insurance ... to vote on a compromise bill to,reauthorize the ... program that provides health insurance coverage to poor,children. ...
... and S.E.VEN, BOSTON, Sept. 24 Small Army, ... a cure for diabetes and,alleviating world poverty to their ... and S.E.VEN. "As communicators, we welcome the challenge ... dollars, but by a commitment,to truly make the world ...
... to Execute and Completeness of Vision, ANDOVER, ... management (IAM) solutions are the most widely implemented ... in the Visionaries,quadrant by Gartner, Inc. in the ... of the Magic Quadrant for User Provisioning, 2H07,(authored ...
... a,leading technology provider of mobile enterprise solutions for ... NASDAQ Stock,Market LLC has approved its application for ... Capital Market. Trading in the Company,s common stock,commenced ... the symbol "IFLG." (Logo: http://www.newscom.com/cgi-bin/prnh/20060209/PHTH052LOGO ...
... CHASKA, Minn., Sept. 24 Tired? Stressed? ... restore, and rejuvenate? The Village Company,( http://www.thevillagecompany.com ... bath,and body products, announces the nationwide launch ... relief from common ailments,( http://www.thevillagecompany.com/vntherapy.html ). ...
... Novo Nordisk, a,world leader in diabetes care, ... the Dow Jones Sustainability World Index (DJSI World) ... 18 global supersectors,analyzed. The latest global analysis ... analysis of companies, economic, environmental and,social performance, assessing ...
Cached Medicine News:Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 2Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 3Health News:Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 3Health News:InfoLogix Announces Approval for NASDAQ Listing 2Health News:InfoLogix Announces Approval for NASDAQ Listing 3Health News:The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments 2Health News:Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes 2
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Neurotechnology: 2014-2018" report to their offering. ... most comprehensive and up-to-date publication available covering the neurotechnology ... technology, markets, competitors, and growth rates in four key ... through 2018. It forecasts the number of systems to ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... and Other Novel Hypercholesterolemia Drugs" report to their ... is a high cholesterol burden despite the presence of ... the available options, statins have been ubiquitously prescribed over ... of plasma LDL cholesterol (LDLC) is the cornerstone of ...
(Date:9/22/2014)... , September 22, 2014 Persistence ... on "Global Market Study on Ophthalmic Devices: ... the global ophthalmic devices market was valued at USD 29,171.5 million ... CAGR of 6.5% from 2014 to 2020, to reach ... Browse the full Global Market Study on Ophthalmic ...
Breaking Medicine Technology:The Market for Neurotechnology: 2014-2018 2PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5
...  Merrimack Pharmaceuticals, Inc. announced today that the first ... clinical study combining MM-121, a fully human monoclonal ... irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety and ...
... Md., Dec. 13, 2011 The U.S. Food and ... device intended to aid in the detection of life-threatening ... spectroscopy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... health care providers identify patients with critical head injuries ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 3
... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Slim bronchoscope designed for paediatric applications....
Medicine Products: